Skip to main content
. 2022 Mar 4;11(5):893. doi: 10.3390/cells11050893

Figure 5.

Figure 5

Elafibranor-mediated upregulation of ANGPTL4, PDK4, and PLIN2 is predicted to induce steatosis functions in in vitro NASH models, contrarily to observed downregulation in patients with resolved NASH due to bariatric surgery. (A) Regulation of steatosis- and inflammation-related functions by PLIN2, ANGPTL4, and PDK4 in PHH, HepaRG, and hSKP-HPC cultures exposed to ‘NASH’ triggers and elafibranor. (B) Differential expression of ANGPTL4, PDK4, and PLIN2 in liver tissue from obesity/NAFLD patients that underwent bariatric surgery.